Ads
related to: prostate cancer patient portal- Oral Medication
Learn More About An Oral Treatment
For Metastatic Prostate Cancer.
- Side Effect Information
Learn More About Potential Side
Effects And Safety Information.
- Genomic Testing
Read How Testing Could
Help Inform Your Treatment Plan.
- Patient Support Program
Learn About A Treatment Option
And Patient Support.
- Oral Medication
Search results
Results From The WOW.Com Content Network
Prostate cancer is a major topic of ongoing research. From 2016 to 2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [122] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost ...
A new method to reduce rectal radiation injury in prostate cancer patients involves the use of an absorbable spacer placed between the prostate and rectum. MRI showing hydrogel spacer pushing the rectum away from the prostate during radiotherapy. Such spacers are commercially available in some regions and are undergoing clinical trials in ...
In 2023, the number of prostate cancer cases rose to 55,033, while breast cancer diagnoses decreased to 47,526. The data also indicates a 25% rise in prostate cancer cases between 2019 and 2023.
Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.
Ultrasound is used for daily patient setup. It is useful for soft tissue such as the breast and prostate. The BAT (Best Nomos) and Clarity (Elekta) systems are the two main systems currently being used. The Clarity system has been further developed to enable intra-fraction prostate motion tracking via trans-perineal imaging.
Prostate cancer is a form of cancer that is typically slow-growing and originates in or on the prostate, a male reproductive gland that surrounds the urethra in proximity of the bladder and rectum. This is a result of malignant cells forming and multiplying at the prostate, which can then spread or metastasize to other organs in the body. [1]
Ads
related to: prostate cancer patient portal